Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

157

Figures (1-3)

Tables (1-5)

Sum=194

Publishing Process of This Article

Item

Count

Browse

Download

Sum=12

May 14, 2025 (publication date) through May 14, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. May 14, 2025; 31(18): 104206
Published online May 14, 2025. doi: 10.3748/wjg.v31.i18.104206

Table 5 Baseline comparison between endoscopic response group and no-response group in Crohn’s disease group

	Endoscopic response group	Endoscopic no-response group	P value
CRP	22.94 (4.20, 41.00)	14.57 (6.45, 64.81)	0.003
CAR	0.67 (0.09, 1.10)	0.37 (0.16, 1.88)	0.026
CLR	20.85 (2.63, 27.04)	8.56 (4.08, 42.85)	< 0.001

CRP: C-reactive protein; CLR: C-reactive protein/lymphocyte; CAR: C-reactive protein/albumin.

Citation: Liu X, Pan LX, Pei JX, Pu T, Wen HT, Zhao Y. Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease. World J Gastroenterol 2025; 31(18): 104206
URL: https://www.wjgnet.com/1007-9327/full/v31/i18/104206.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i18.104206